---
layout: post
title: "Priority Zoonotic Animal Drug Designation and Review Process; Draft Guidance for Industry; Availability"
date: 2026-02-05 18:57:59 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2023-27655
original_published: 2023-12-18 00:00:00 +0000
significance: 8.00
---

# Priority Zoonotic Animal Drug Designation and Review Process; Draft Guidance for Industry; Availability

**Published:** February 05, 2026 18:57 UTC
**Source:** Federal Register
**Original Published:** December 18, 2023 00:00 UTC
**Document Number:** 2023-27655

## Summary

The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for industry (GFI) #283 entitled "Priority Zoonotic Animal Drug Designation and Review Process." This draft guidance is intended to assist sponsors pursuing priority zoonotic animal drug (PZAD) designation for a new animal drug. This draft guidance is intended to provide the eligibility criteria for PZAD designation, the process for requesting PZAD designation, and enhancements in the FDA review process for PZADs.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2023/12/18/2023-27655/priority-zoonotic-animal-drug-designation-and-review-process-draft-guidance-for-industry)
- API: https://www.federalregister.gov/api/v1/documents/2023-27655

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
